Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD — a Systematic Review and Meta-Analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1473-4230
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD — a Systematic Review and Meta-Analysis ; day:7 ; month:9 ; year:2021 ; pages:1-34
The cerebellum ; (7.9.2021), 1-34
- Creator
-
Kaliszewska, Aleksandra
Allison, Joseph
Col, Tarik-Tarkan
Shaw, Christopher
Arias, Natalia
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12311-021-01320-0
- URN
-
urn:nbn:de:101:1-2021111918043108658165
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kaliszewska, Aleksandra
- Allison, Joseph
- Col, Tarik-Tarkan
- Shaw, Christopher
- Arias, Natalia
- SpringerLink (Online service)
Other Objects (12)
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids
Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ ALS/FTD is rescued by SV 2 replenishment
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids
Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ ALS/FTD is rescued by SV 2 replenishment
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD
Specific biomarkers for C9orf72 FTD/ALS could expedite the journey towards effective therapies
Molecular pathology, developmental changes and synaptic dysfunction in (pre-) symptomatic human C9ORF72-ALS/FTD cerebral organoids
Synaptic dysfunction induced by glycine‐alanine dipeptides in C9orf72‐ ALS/FTD is rescued by SV 2 replenishment
A familial FTD associated with C9orf72 repeat expansion and dysplastic gangliocytoma
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTD
Nuclear lamina invaginations are not a pathological feature of C9orf72 ALS/FTD
Aktive und passive anti-GA Immuntherapie für C9orf72 ALS/FTD im Mausmodell
RNA dependent suppression of C9orf72 ALS/FTD associated neurodegeneration by Matrin-3
Targeting RNA G‐quadruplexes as new treatment strategy for C9orf72 ALS/FTD
Synaptic localization of C9orf72 regulates post-synaptic glutamate receptor 1 levels
Divergence, Convergence, and Therapeutic Implications: A Cell Biology Perspective of C9ORF72-ALS/FTD